Tim Ravenscroft Lentigen Bio Maryland Bio Boston 2012


“Think about this as a disruptive technology,” said Tim Ravenscroft, Lentigen’s CEO. “We’re not looking here at incremental improvements for patients. We’re looking at disease cures and really transforming a lot of these diseases for patients. This is not like a slight improvement on an existing therapy. We’re trying to really transform the way patients are managed.” Read more.
 
 
 
Background_footer
© Copyright 2012 Lentigen Corporation. All Rights Reserved.    + Privacy Policy    + Terms of Use